Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

Fig. 5

Correlations between changes in the 6-min walk test distance (6MWTD, from baseline values to 6-month values) and changes in the mitral E/e′ ratio during exercise a mitral annular relaxation velocity (e′) at rest b or during exercise c in patients treated with empagliflozin for 6 months

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840